Effect of intraperitoneal erythropoietin on the degree of mucosal damage of left colon flaps in rats.
BACKGROUND
Several modifications to an esophageal replacement approach have been described, using the left, the right, or the transverse colon as an interposition flap. Interposition of the left colon has become the most popular procedure. Intraoperative clamping of the arterial blood supply and venous drainage of the flap is a possible reason for ischemic flap failure. Thus, we designed a novel model to investigate whether erythropoietin (EPO), which has a tissue-protective effect in ischemia, would have any protective effect on prepared colon flaps in rats.


METHODS
A total of 56 rats were randomly divided into four main groups, consisting of sham, sham + EPO, colon flap, and colon flap + EPO, and each main group was divided into two sub-groups. In the colon flap and colon flap + EPO groups, the colon flap was prepared and the pediculated free flap fixed tautly to the anterior abdominal wall. The sub-groups were subjected to post-reoperative histopathological investigation on the first and the seventh days, respectively.


RESULTS
Our model was reliable for research related to colon interposition techniques. There was significant histopathological damage in the colon flap group both for the long and short limbs of the flap. On the other hand, EPO administration prevented the mucosal damage seen in the colon flap group.


CONCLUSIONS
This study suggests that a colon flap attached tautly to the abdominal side wall simulates colon transposition techniques and also shows that intraperitoneal EPO markedly decreases flap damage in rats with prepared colon flaps.
Turk
Erdal
E
Department of Pediatric Surgery, Dr. Behcet Uz Children's Hospital, Izmir, Turkey. eturk19@yahoo.de
Karaca
Irfan
I
Karkiner
Aytac
A
Evciler
Hüseyin
H
Ortac
Ragip
R
Temir
Z Gunyuz
ZG
Ucan
Basak
B
Yayla
Derya
D
D043925:Angiogenesis Inducing Agents / Q000008:administration & dosage*; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage; D003106:Colon / Q000098:blood supply / Q000187:drug effects* / Q000637:transplantation; D004195:Disease Models, Animal; D004921:Erythropoietin / Q000008:administration & dosage*; D007413:Intestinal Mucosa / Q000098:blood supply / Q000187:drug effects*; D007511:Ischemia / Q000517:prevention & control*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D013524:Surgical Flaps
D043925:Angiogenesis Inducing Agents; D000975:Antioxidants; D004921:Erythropoietin